Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data
05/05/2026 22:29
May 5 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O: VERRICA PHARMACEUTICALS ANNOUNCES UPCOMING PRESENTATION OF PHASE 2 DATA HIGHLIGHTING THE POTENTIAL ABSCOPAL EFFECTS OF VP-315 IN THE TREATMENT OF BASAL CELL CARCINOMA AT THE 2026 SOCIETY FOR INVESTIGATIVE DERMATOLOGY (SID) ANNUAL MEETING Source text: ID:nGNX37RbDH Further company coverage: VRCA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data